Skip to Content

BCAL Diagnostics Ltd Ordinary Shares - Stock Quote BDX

Rating as of

Morningstar's BCAL Diagnostics Ltd Ordinary Shares Stock Analysis

Valuation
Currency in AUD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - BDX

BCAL Diagnostics Ltd Ordinary Shares's Company Profile

Business Description

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.

Contact
50 Clarence Street, Suite 506, Level 5
Sydney, NSW, 2000, Australia
T +61 290787671
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Jun 30, 2021
Stock Type
Employees